Australia - English - Department of Health (Therapeutic Goods Administration)

phenox australia pty ltd - 61779 - thrombectomy wire-net - the preset/preset lite thrombectomy devices consists of a self-expanding nitinol structure that carries one radiopaque platinum/iridium coil-marker on its proximal end and two markers on its distal end. the structure is firmly attached to a pusher wire on its proximal end. this pusher wire is covered with a ptfe tubing in order to reduce friction during use. the retrieval device is stored in compressed form in an introducer sheath. the preset and preset lite thrombectomy devices are indicated for mechanical clot retrieval from intracranial arteries as acute ischemic stroke treatment. candidates for treatment are patients who are ineligible for intravenous tissue plasminogen activator (iv t-pa), patients who fail iv t-pa therapy and patients who require a supplement treatment to an initiated iv t-pa therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

hydrix services pty ltd - 60940 - neurovascular embolization coil - the wallaby avenir? coil system (acs) consists of a platinum implantable coil attached to a delivery pusher. the delivery pusher provides a means to deliver the embolization coil to the vascular target treatment site and is designed to mechanically detach the coil from the delivery pusher. once a frame has been established by one or more framing coils, additional acs framing coil, filling coils, and finishing coils can be deployed to provide embolization of the aneurysm or lesion. the wallaby avenir? coil system is indicated for the endovascular embolization of intracranial aneurysms and other neurovascular abnormalities, such as arteriovenous malformations and arteriovenous fistulae.

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

cont_eth -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

cont_eth -

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

cont_eth -

European Union - English - EMA (European Medicines Agency)

teva b.v. - doxorubicin hydrochloride - breast neoplasms - antineoplastic agents - myocet liposomal, in combination with cyclophosphamide, is indicated for the first-line treatment of metastatic breast cancer in adult women.

United States - English - NLM (National Library of Medicine)

demoulas super markets - eucalyptol 0.092%, menthol 0.042%, methyl salicylate 0.060%, thymol  0.064%, antigingivitis, antiplaque - eucalyptol 0.092 kg in 100 l - helps control plaque that leads to gingivitis

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

r-pharm germany gmbh - celecoxib - capsules - 200mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

r-pharm germany gmbh - celecoxib - capsules - 100mg

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - acetazolamide (unii: o3fx965v0i) (acetazolamide - unii:o3fx965v0i) - for adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. acetazolamide tablets are also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness in climbers attempting rapid ascent and in those who are very susceptible to acute mountain sickness despite gradual ascent. hypersensitivity to acetazolamide or any excipients in the formulation. since acetazolamide is a sulfonamide derivative, cross sensitivity between acetazolamide, sulfonamides and other sulfonamide derivatives is possible. acetazolamide therapy is contraindicated in situations in which sodium and/or potassium blood serum levels are depressed, in cases of marked kidney and liver disease or dysfunction, in suprarenal gland failure, and in hyperchloremic acidosis. it is contraindicated in patients with cirrhosis because of the risk of development of hepatic encephalopathy. long-term administration of acetazolamide is contraindicated in patients with chronic noncongestive angle-closure glaucoma since it may permit organic closure of the angle to occur while the worsening glaucoma is masked by lowered intraocular pressure.